32 parallel-computing-numerical-methods-"Simons-Foundation" uni jobs at Ghent University
Sort by
Refine Your Search
-
with plasma-polymerized coatings and biomolecules to promote skin regeneration. In parallel, plasma-treated liquids (PTLs) enriched with reactive oxygen and nitrogen species (RONS) will be developed
-
art scene and numerous world-class museums, covering ancient, modern and contemporary art, folklore and industrial heritage. The city is also home to a wide range of performing arts centers. The vibrant
-
– to study meiotic recombination - and bioinformatics, sequencing and other omics tools. You will optimise methods and develop innovative approaches and apply them in maize. In practice, you will mainly work
-
Rankine Cycle (ORC). The goal is to model this complex process using computational fluid dynamics (CFD), taking into account thermodynamic non-equilibrium. The developed method can then serve as the
-
Framework Programme? Not funded by a EU programme Is the Job related to staff position within a Research Infrastructure? No Offer Description → Apply before 03/09/2025 (DD/MM/YYYY) 23:59 (Brussels Time
-
Deadline 9 Sep 2025 - 21:59 (UTC) Type of Contract Temporary Job Status Full-time Hours Per Week 38 Is the job funded through the EU Research Framework Programme? Not funded by a EU programme Is the Job
-
(also named spheroids) (Peirsman&Blondeel et al. Nature Methods 2021), patient-derived tumor fragments (Vermeulen et al. Sci Rep 2024) and patient-derived orthotopic xenograft mouse models (Fischer et al
-
Laboratory of Integrative Metabolomics, an established research group with extensive experience in both experimental and computational metabolomics. The current focus of the computational branch of our
-
technologies or scientific developments (such as artificial intelligence, synthetic biology, climate engineering, …). The project is grounded in an interpretive social science research design, in which methods
-
Biotechnology (https://cmb.sites.vib.be ). Through this multidisciplinary team, the candidate will have access to state-of-the-art technologies (massive parallel sequencing, mass spectrometry-based proteomics